Voices of patients with hemophilia: Life‐changing gene therapy

Documenti analoghi

• Haemophilia Prophylaxis in the Age of Innovation: Exploring Opportunities for Personalized Treatment
  di: Yesim Dargaud, et al.
  Pubblicazione: (2025)
• In vitro combined haemostatic efficacy of emicizumab and extended half‐life factor VIII compounds
  di: Laurie Josset, et al.
  Pubblicazione: (2025)
• Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B
  di: Brigitte Tardy‐Poncet, et al.
  Pubblicazione: (2024)
• Utilising Thrombin Generation Assay to Guide Co‐Administration of Factor Therapies With Fitusiran
  di: Yesim Dargaud, et al.
  Pubblicazione: (2025)
• Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network
  di: Sandrine Meunier, et al.
  Pubblicazione: (2024)